ISCO 8-K 2026-07-15

International Stem Cell CORP (ISCO) 8-K dated 2026-07-15 — accession 0001683168-26-005555. This URL is the filing, not the ISCO hub.

International Stem Cell CORP (ISCO) is a biotechnology company listed on US.

International Stem Cell CORP filed a 8-K on 2026-07-15. Accession 0001683168-26-005555.

Cached items: 1.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ISCO revenue for 2026-06-30 was $5.0M. Net income was -$291.0K. ISCO currently screens at market cap $880.5K.

Not investment advice. The ISCO SEC hub lists recent forms. The stock page is the research view.